| TRADING CENTER |
| Biogen Beats & Guides Higher - Analyst Blog - Zacks.com | |
| Biogen 4th-qtr profit up, outlook tops estimates - Reuters | |
| Company News for February 9, 2010 - Corporate Summary - Zacks.com | |
| Biogen 4th-qtr profit up; outlook tops estimates - Reuters | |
| Greece Debt: Tuesday's Headlines - at TheStreet.com | |
| Biogen Idec Offers 2010 Guidance: BioBuzz - at TheStreet.com | |
| Stocks in the News: Toyota, Electronic Arts, Coca-Cola - DailyFinance | |
| Biogen 4th-qtr profit up; price rises help sales - Reuters | |
| Biogen Idec Reports Full Year and Fourth Quarter 2009 Results - Business Wire | |
| US warns of risk rise with more Tysabri infusions - Reuters | |
| A Drugless Drugmaker IPO! - MotleyFool.com | |
| New Zacks.com Research Report for Biogen Idec Inc.(BIIB) ($) - Zacks.com | |
| Pfizer's Hedge Pays Off - MotleyFool.com | |
| Wake Up! You Still Have to Pay Attention - MotleyFool.com | |
| Icahn Back to Batter Biogen - MotleyFool.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.21 | -0.25 / -0.44% | 11.65 |
| GILD | Gilead Sciences Inc | 46.30 | 0.21 / 0.46% | 15.13 |
| CELG | Celgene Corporation | 55.50 | 0.73 / 1.33% | 26.68 |
| 2008 Revenue: | $4.1 B | Headquarters: Cambridge, MA |
| Employees: | 4,700 | CEO: James C. Mullen |
| Net Income: | $783.2 M | Industry: Biotechnology |
| Market Cap: | $15.3 B | Website: www.biogenidec.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| BIIB | 54.09 | +1.25 / +2.37% | 52.84 | 54.88 | 53.33 | Profile Chart News |